Study Details

Back
Study ID 905-CL-013
Study Title A randomized, double-blind, placebo-controlled, parallel-group, fixed-dose, multicenter study to assess efficacy and safety of daily oral administration of 10 mg YM905 (solifenacin succinate) versus placebo in male and female patients with overactive bladder
Clinicaltrials.gov Identifier Not Applicable
Compound Name YM905 / solifenacin succinate
Medical Indication or Disease Overactive bladder
Study Sponsor Yamanouchi Pharma America Inc
Collaborator Not Applicable
Study Start Date 05-Feb-2001
Study Completion Date 17-Oct-2001
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS